What is Leerink Partnrs’ Estimate for ALDX Q2 Earnings?
Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Free Report) – Analysts at Leerink Partnrs issued their Q2 2025 earnings estimates for Aldeyra Therapeutics in a note issued to investors on Sunday, April 13th. Leerink Partnrs analyst M. Goodman forecasts that the biotechnology company will earn ($0.23) per share for the quarter. The consensus estimate for Aldeyra Therapeutics’ […]
More Stories
California Leads Nation in Diesel Price Spike
By Bill Pan Diesel prices are rising across the nation, and California is taking an especially hard hit, as recent...
Trump Endorses Steve Hilton in Heated Race for California Governor
By Jill McLaughlin Republican Steve Hilton captured President Donald Trump’s endorsement on April 5 in his quest to become the...
Race to Secure Iran Cease-Fire Intensifies as Trump Ultimatum Ticks Down
By Chris Summers Efforts to revive cease-fire negotiations between the United States and Iran intensified on April 6 as regional...
Is Resume Genius Legit? Pricing, Features, and Cancellation Policy
Whether you are a working professional or a student, in your life, you must have searched for an online resume...
How Career-Focused College Scholarships for Students Help Today’s Graduates Afford College and Hit the Workforce Job-Ready
College is a big investment, and students want more than a diploma. They want a fair price and a clear...
Trump Threatens to Target Iran’s Bridges, Power Plants on April 7 if Strait of Hormuz Not Reopened
By Jacki Thrapp U.S. President Donald Trump has threatened to target Iran’s power plants and bridges on April 7 if...